Search

everythinglearnresearchcommunity

for

Search:↓

Triptorelin effectively treats central precocious puberty in Chinese children with minimal side effects.

Etrasimod is safe but not effective for severe alopecia areata, though it may help milder cases.

More research is needed on the safety of fathers' drug exposure before conception.

Pediatric pemphigus is often diagnosed late, but rituximab helps control it long-term.

PRP may improve early ACL healing, but long-term effects are unclear.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Platelet-Rich Fibrin (PRF) can speed up healing in chronic wounds, improve hair density, and act as a natural filler for skin rejuvenation, but its use in hair loss treatment needs more evaluation.

PRP is a safe and effective treatment for hair growth in alopecia areata.

Risankizumab may help manage symptoms of dissecting cellulitis of the scalp.

The new drug delivery system improves vitiligo treatment by enhancing melanocyte activity and viability.

Leflunomide successfully treated a rare skin condition in a liver transplant patient.

Platelet-Rich Plasma (PRP) is a safe and effective tool for facial rejuvenation and scar treatment.

Radiotherapy can cause skin fibrosis, which is often overlooked and needs better treatment and evaluation.

Platelet-rich plasma may improve vitiligo treatment when used with phototherapy.

Deucravacitinib helped regrow hair and reduce plaques in a woman with discoid lupus erythematosus without side effects.

Revertant cell therapy could be a future treatment for Ichthyosis with confetti.

Ion-paired risedronate significantly increases skin penetration without irritation compared to risedronate alone.

iL-PRF treatment improves hair growth for androgenetic alopecia.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

PRP shows promise in healing and regeneration but needs standardized protocols for consistent results.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Mycophenolate mofetil is safer and more effective than cyclophosphamide for treating lupus nephritis.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Oral Janus kinase inhibitors are effective for treating alopecia areata in adults.

CRISPR gene editing reduces harmful molecules in cells from Emery–Dreifuss Muscular Dystrophy patients.

A man's skin cancer improved and some of his hair grew back after treatment with a special light therapy and a medication.

Fexofenadine reduces discomfort but doesn't significantly improve hair regrowth in Alopecia Areata treatment.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.